Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DJM3W0
|
|||
Drug Name |
RZ358
|
|||
Drug Type |
Antibody
|
|||
Indication | Congenital hyperinsulinism [ICD-11: 5A4Y] | Phase 2 | [1] | |
Company |
Rezolute
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT04538989) An Open-Label Multiple-Dose Study of RZ358 in Patients With Congenital Hyperinsulinism. U.S.National Institutes of Health. | |||
REF 2 | Clinical pipeline report, company report or official report of Rezolute |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.